DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer

  1. Martinez-Useros, J.
  2. Rodriguez-Remirez, M.
  3. Borrero-Palacios, A.
  4. Moreno, I.
  5. Cebrian, A.
  6. Gomez del Pulgar, T.
  7. del Puerto-Nevado, L.
  8. Vega-Bravo, R.
  9. Puime-Otin, A.
  10. Perez, N.
  11. Zazo, S.
  12. Senin, C.
  13. Fernandez-Aceñero, M.J.
  14. Soengas, M.S.
  15. Rojo, F.
  16. Garcia-Foncillas, J.
Journal:
BMC Cancer

ISSN: 1471-2407

Year of publication: 2014

Volume: 14

Issue: 1

Type: Article

DOI: 10.1186/1471-2407-14-965 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus